This page contains affiliate links. We may earn a commission at no extra cost to you.

$10–$25 for a 90-day supply

Check Price on Amazon
Evidence: Strong for B12-deficiency neuropathy — correcting deficiency can substantially reverse neuropathy. Moderate for supplementation in non-deficient patients — Japanese RCTs show benefit with pharmacological doses. Widely recommended as a standard baseline supplement in neuropathy management.

Vitamin B12 deficiency is one of the most common and most treatable causes of peripheral neuropathy — and deficiency is far more prevalent than most patients and physicians realize. The active form of B12 used in nerve tissue, methylcobalamin, is directly involved in myelin synthesis, axonal transport, and the methylation reactions required to maintain nerve cell DNA. Deficiency causes a demyelinating neuropathy that, if caught early, can be substantially reversed with supplementation. Methylcobalamin is preferable to the less expensive cyanocobalamin form (found in most generic B12 supplements) because it is already in the bioactive form and does not require conversion by the liver. For diabetic patients on metformin, for anyone over 60, and for those on proton pump inhibitors — B12 deficiency risk is elevated and checking levels before and during treatment is worthwhile.

How It Works

Vitamin B12 is required as a cofactor for two critical enzymatic reactions in the body: the conversion of homocysteine to methionine (essential for myelin synthesis and DNA methylation) and the conversion of methylmalonyl-CoA to succinyl-CoA (essential for myelin lipid production and energy metabolism in nerve cells). Deficiency in either pathway impairs myelin formation and maintenance, eventually leading to demyelination of peripheral and central nervous system fibers.

Methylcobalamin, unlike cyanocobalamin, is the form directly active in the methionine synthesis reaction — meaning it can be used by cells without any conversion step. It may also have direct neuroprotective effects independent of B12 deficiency: research suggests methylcobalamin at pharmacological doses promotes nerve regeneration by stimulating protein synthesis in damaged axons and increasing the availability of neurotrophic factors. Japanese clinical research has explored high-dose methylcobalamin (1,500 mcg to 10,000 mcg daily) as a treatment for established neuropathy even in patients without documented B12 deficiency, with several studies showing modest but positive effects.

Who Is Most at Risk for B12 Deficiency

Vitamin B12 deficiency is common and underdiagnosed. Normal absorption requires intrinsic factor (produced by stomach cells) and an intact terminal ileum. Any condition disrupting this pathway raises deficiency risk significantly. Patients most at risk include: anyone over 60 (stomach acid and intrinsic factor production decline with age); metformin users (metformin interferes with B12 absorption in the gut — up to 30 percent of long-term metformin users become deficient); people on long-term proton pump inhibitors (omeprazole, pantoprazole, etc.); vegans and strict vegetarians (B12 is found almost exclusively in animal products); and patients with Crohn’s disease, celiac disease, or prior gastric surgery.

Blood testing for B12 is important — but standard serum B12 levels can be misleading. A serum B12 in the low-normal range (200–400 pg/mL) may still represent functional deficiency in nerve tissue. More sensitive markers include serum methylmalonic acid (MMA) and homocysteine — elevated levels of these indicate functional B12 deficiency even when serum B12 appears borderline adequate. Ask your doctor to check MMA and homocysteine if you have neuropathy and borderline B12 levels.

Methylcobalamin vs. Cyanocobalamin

Most generic B12 supplements and fortified foods use cyanocobalamin — the least expensive synthetic form. Cyanocobalamin must be converted by the liver to the active methylcobalamin and adenosylcobalamin forms before use, a process that is less efficient in some individuals (particularly those with MTHFR gene variants or liver disease). Methylcobalamin is the form directly active in nerve-related methylation reactions and is better suited for neurological applications.

For sublingual administration, methylcobalamin is particularly preferable because it bypasses both the intrinsic factor dependency and the liver conversion step, going directly into the bloodstream. Hydroxocobalamin — another active form used in injections — is also effective and is the preferred form for injections in some countries. The bottom line: for neuropathy support, methylcobalamin is the recommended form over cyanocobalamin.

Pharmacological Dosing for Neuropathy

Standard dietary reference intakes for B12 (around 2.4 mcg per day for adults) are insufficient for therapeutic neuropathy purposes. Clinical protocols for B12-deficiency neuropathy use 1,000 mcg (1 mg) daily or more. At these doses, even patients with impaired intrinsic factor-dependent absorption can absorb adequate amounts through passive diffusion in the gut — meaning high-dose oral supplementation can treat B12 deficiency effectively in most patients without requiring injections.

For patients with documented severe deficiency, intramuscular or subcutaneous injections remain an option for rapid repletion, after which high-dose oral maintenance is typically sufficient. Japanese research protocols using pharmacological doses of methylcobalamin (1,500 mcg three times daily or 10,000 mcg daily) for non-deficient neuropathy patients suggest that high-dose methylcobalamin may have neuroprotective effects beyond simple deficiency correction — though this approach has not been broadly adopted in Western clinical guidelines.

Pros

• Directly active form — no liver conversion required, better suited for neurological applications than cyanocobalamin
• Can reverse neuropathy substantially if deficiency is caught early
• Essential and low-cost baseline supplement for high-risk groups (metformin users, elderly, vegans)
• High-dose oral supplementation can treat deficiency without injections in most cases
• Excellent safety profile — B12 has no established toxic upper limit

Cons

• Benefit is greatest in deficiency states — less clear benefit in truly replete patients beyond standard nutritional support
• Blood testing is required to establish deficiency and monitor treatment response
• Standard serum B12 testing can be misleading — MMA and homocysteine tests are more sensitive

Frequently Asked Questions

Can B12 deficiency neuropathy be reversed?

Yes — if caught early, before severe axonal degeneration has occurred, B12-deficiency neuropathy can be substantially and sometimes completely reversed with adequate supplementation. The earlier treatment begins, the better the neurological outcome. Long-standing severe deficiency may cause permanent damage, but even then, halting progression and achieving partial recovery is possible.

Should metformin users routinely take methylcobalamin?

Many physicians and endocrinologists now recommend annual B12 testing for patients on metformin and supplementation for those in the low-normal or deficient range. The American Diabetes Association’s Standards of Care specifically notes that long-term metformin use may be associated with B12 deficiency and recommends periodic testing. If you are on metformin and have neuropathy symptoms, checking your B12 with methylmalonic acid and homocysteine is a high-priority step.

Do I need injections, or will oral B12 work?

For most patients with B12 deficiency — even those with impaired intrinsic factor production — high-dose oral methylcobalamin (1,000–2,000 mcg daily) is effective at restoring B12 levels and is more convenient than injections. Injections are sometimes preferred for patients with severe deficiency requiring rapid repletion, those with absorption issues that make oral supplementation less reliable, or patients who prefer injections. Discuss the options with your doctor.

Buy on Amazon — $10–$25 for a 90-day supply